What is the appropriate treatment for Streptococcus canis infection?

Treatment of Streptococcus canis Infection

Treat Streptococcus canis infections with intravenous penicillin G or beta-lactam antibiotics, as this organism remains highly susceptible to penicillins despite increasing antibiotic resistance patterns. 1, 2, 3

Antibiotic Selection

First-Line Therapy

• Penicillin G (IV) is the treatment of choice for serious infections

  • Used successfully in documented cases of S. canis bacteremia with metastatic complications (osteomyelitis, myositis, abscess) 3
  • An 8-week course of IV penicillin G achieved complete resolution in a case with extensive bone and soft tissue involvement 3

• Beta-lactams with beta-lactamase inhibitors (e.g., amoxicillin-clavulanate) are recommended when beta-lactamase activity is suspected

  • 94% (50/53) of S. canis strains showed sensitivity to penicillins in veterinary studies 2
  • Beta-lactamase activity has been identified among penicillin-resistant strains 2

Alternative Agents

• Ceftriaxone is an effective alternative

  • Successfully used in a case of S. canis sepsis with complete recovery 4
  • Provides broader coverage if polymicrobial infection is suspected

• Cefazolin can be considered for soft tissue infections 3

Critical Clinical Considerations

Screen for Metastatic Infection

S. canis bacteremia requires aggressive evaluation for disseminated disease:

• Obtain imaging (CT/MRI) to evaluate for osteomyelitis, myositis, and abscess formation 3
• Perform echocardiography to rule out endocarditis 3
• This pathogen has demonstrated capacity for severe metastatic complications including sacroiliitis, paraspinal abscesses, and bone infection 3

Severity Stratification

• Neonatal sepsis: Mortality rate of 26% in reported cases 1

  • Requires immediate empiric beta-lactam therapy with or without aminoglycosides 1
  • Rapidly progressive and potentially fatal course 1

• Adult infections: Generally favorable outcomes with prompt treatment 5

  • 52/54 patients had favorable outcomes with appropriate antibiotics 5
  • Two deaths occurred from sepsis, emphasizing need for early recognition 5

Treatment Duration

• Soft tissue infections: 7-14 days based on IDSA guidelines for skin and soft tissue infections 6
• Bacteremia with metastatic complications: 6-8 weeks of IV therapy 3
• Uncomplicated bacteremia: Minimum 2 weeks, guided by clinical response

Important Pitfalls

Antibiotic Resistance Patterns

• Avoid quinolones: Despite frequent empiric use by clinicians (63% of cases), quinolone resistance rates are 38-59% 2
• Multidrug resistance is common: 70% of strains show resistance to three or more antibiotic classes 2
• However, penicillin susceptibility remains preserved in the vast majority of isolates 2, 5
• One pathogenic clonal complex (CC13) has shown resistance to vancomycin and linezolid 2

Polymicrobial Nature

• 77.8% of cultures (excluding blood cultures) are polymicrobial 5
• Consider broader coverage if clinical response to penicillin is inadequate
• Distinguish true infection from colonization, particularly in non-sterile sites 5

Zoonotic Transmission

• Obtain history of animal contact, particularly dogs and cats 4, 7
• No bite or scratch wound is necessary for transmission 3
• Genomic evidence suggests potential for inter-species transmission including zoonotic transfer 7

Infectious Diseases Consultation

Management should involve infectious diseases consultation given the potential for severe metastatic infection and the relative rarity of this pathogen in human medicine 3.